Cellectis SA (CLLS) has released an update.
At Cellectis SA’s Annual Shareholders Meeting on June 28, 2024, several key resolutions were passed with overwhelming support, including the approval of annual and consolidated financial statements, allocation of financial results, and the renewal of Mr. André Choulika’s board membership. Votes showcased a strong consensus among shareholders, with approvals consistently above 98%, demonstrating solid backing for the company’s proposed actions and governance.
For further insights into CLLS stock, check out TipRanks’ Stock Analysis page.
